Simplex Trading
TERN

Simplex Trading’s Terns Pharmaceuticals TERN Stock Holding History

Simplex Trading’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,650
Closed -$93.5K – 10064
2025
Q2 		$54K Buy
+14,650
New +$45.8K ﹤0.01% 5855
2024
Q4 		– Sell
-3,690
Closed -$25K – 9612
2024
Q3 		$30K Sell
3,690
-17,553
-83% -$144K ﹤0.01% 6362
2024
Q2 		$144K Buy
+21,243
New +$129K ﹤0.01% 4981
2024
Q1 		– Sell
-170
Closed -$1.11K – 9881
2023
Q4 		$1K Buy
+170
New +$899 ﹤0.01% 8586
2023
Q3 		– Sell
-40,885
Closed -$259K – 9812
2023
Q2 		$357K Buy
+40,885
New +$477K ﹤0.01% 3654

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Simplex Trading's TERN Position: Q3 2025 in Review

Simplex Trading sold out of Terns Pharmaceuticals (TERN) in Q3 2025, closing a stake of 14,650 shares — an estimated $93.5K sold.

Simplex Trading first reported a position in TERN in Q2 2023 and held it in 5 quarters. The position peaked at $357K in Q2 2023. 141 funds tracked by Wall St. Rank hold TERN as of Q3 2025.

  • Simplex Trading reported no remaining Terns Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 14,650 Terns Pharmaceuticals shares in Q3 2025, an estimated $93.5K.
  • Simplex Trading first reported a position in Terns Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • Simplex Trading's Terns Pharmaceuticals position peaked at $357K in Q2 2023.
  • 141 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.